Metraipolis › archive › dc_ea132807ce9f

Mepolizumab as a Possible Treatment for Eosinophilic Ureteritis — Europe PMC PMID:42078231

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42078231
DOI
10.7759/cureus.106338
License (as archived)
solo-consultazione
Archived
2026-11-03T12:25:29.156Z
SHA-256 of the archived text
d57e7af0158550b1037d8936b00c90e72960821ce338d1a208d9716753b9b915
Stable URL of this page
https://metraipolis.com/documento/dc_ea132807ce9f

How to cite

Mepolizumab as a Possible Treatment for Eosinophilic Ureteritis — Europe PMC PMID:42078231 — Europe PMC (en), https://europepmc.org/article/MED/42078231 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea132807ce9f (Metraipolis archive dc_ea132807ce9f, sha256 d57e7af0158550b1037d8936b00c90e72960821ce338d1a208d9716753b9b915)
BibTeX
@misc{dcea132807ce9f,
  title = {Mepolizumab as a Possible Treatment for Eosinophilic Ureteritis — Europe PMC PMID:42078231},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42078231},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea132807ce9f; sha256 d57e7af0158550b1037d8936b00c90e72960821ce338d1a208d9716753b9b915},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42078231. Agents can read the archived copy with the MCP tool read_document.